The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating internal blood clots, the company said.
Drug maker Johnson & Johnson is seeking approval from the Food and Drug Administration for a drug to treat patients with deep vein thrombosis or pulmonary embolism, the company said.
A pill-based anticoagulant drug under development by Pfizer and Bristol-Myers Squibb worked better in reducing...